-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to further cooperate with the implementation of policies concerning innovative drugs in the “Drug Administration Law” and “Measures for the Administration of Drug Registration”, under the deployment of the State Drug Administration, the Center for Drug Evaluation has organized and formulated the “Innovative Drugs (Chemical Drugs) During Clinical Trials Change of Technical Guiding Principles (Trial)".
In accordance with the requirements of the "Notice of the General Department of the State Drug Administration on Issuing the Procedures for Issuing the Technical Guidelines for Drugs" (Yao Jian Zong Yao Guan [2020] No.
9), it is hereby issued upon review and approval by the State Drug Administration, as of the date of publication From implementation.
announce.
Center for Drug Evaluation of the National Medical Products Administration
March 3, 2021
In accordance with the requirements of the "Notice of the General Department of the State Drug Administration on Issuing the Procedures for Issuing the Technical Guidelines for Drugs" (Yao Jian Zong Yao Guan [2020] No.
9), it is hereby issued upon review and approval by the State Drug Administration, as of the date of publication From implementation.
announce.
Center for Drug Evaluation of the National Medical Products Administration
March 3, 2021
